Your browser doesn't support javascript.
loading
Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.
Sherman, Scott K; Lange, Joel J; Dahdaleh, Fadi S; Rajeev, Rahul; Gamblin, T Clark; Polite, Blase N; Turaga, Kiran K.
Affiliation
  • Sherman SK; Department of Surgery, University of Chicago, Chicago, Illinois.
  • Lange JJ; Department of Surgery, Medical College of Wisconsin, Milwaukee.
  • Dahdaleh FS; Department of Surgery, University of Chicago, Chicago, Illinois.
  • Rajeev R; Department of Surgery, University of Texas Rio Grande Valley, Edinburg.
  • Gamblin TC; Department of Surgery, Medical College of Wisconsin, Milwaukee.
  • Polite BN; Department of Medicine, University of Chicago, Chicago, Illinois.
  • Turaga KK; Department of Surgery, University of Chicago, Chicago, Illinois.
JAMA Oncol ; 5(2): 236-242, 2019 02 01.
Article in En | MEDLINE | ID: mdl-30489611
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Drug Costs / Capecitabine / Bevacizumab Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: JAMA Oncol Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Drug Costs / Capecitabine / Bevacizumab Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: JAMA Oncol Year: 2019 Document type: Article